Clear Search
·
5 Min Read

Jan. 9, 2026: National Advocacy Update

Telehealth flexibilities for prescribing controlled substances extended and more in the latest National Advocacy Update.

Advocacy Update
Physician or health care professional reviewing patient lab results on a computer desktop
UPDATED
·
3 Min Read

Addressing and managing drug shortages

The AMA has declared drug shortages to be an urgent public health crisis. Stay informed and access resources to address the impacts on practice.

Federal Advocacy
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Dec. 22, 2025

In the news: Similar genetics may drive multiple psychiatric conditions, FDA approves oral semaglutide pill, COVID-19 may have link to chronic conditions and more.

Publications & Newsletters
Doctor prescribing pharmacy to patient
·
4 Min Read

Cross DEA training requirement off your final-year residency checklist

Before you transition to practice, you must complete your MATE Act-required DEA training. An AMA Ed Hub course is tailored for your needs.

series
Transition to Attending
Transitioning to Practice
UPDATED
·
2 Min Read

Drug coverage & spending: Council on Medical Service reports

Download PDFs of council reports that have proposed strategies to address high and escalating prescription drug prices and costs, including promoting transparency and pharmaceutical market competition, combating anti-competitive practices, and outlining criteria for value-based pricing and prescription drug importation.

Medical Service
UPDATED
·
2 Min Read

Consumer-driven health care: Council on Medical Service reports

Download PDFs of key council reports that advance policies that emphasize patient choice and control of their health care by addressing high-value care, retail/store-based clinics, addiction treatment centers, genetic/genomic precision medicine, telemedicine, insurance coverage options, reference pricing, prescription drugs, and hospital care coordination.

Medical Service
Person colored with bright psychedelic paint
·
4 Min Read

Nonclinical psilocybin use soars. What should be done now?

A JAMA Psychiatry study shows a sharp increase in use of psilocybin mushrooms. Learn more, plus discover what interests you from across the JAMA Network.

Publications & Newsletters
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Oct. 27, 2025

In the news: Stillbirths more common in U.S. than previously reported, GLP-1s show promise in treating substance use disorders and more. 

Publications & Newsletters
·
6 Min Read

Oct. 31, 2025: National Advocacy Update

FDA issues new guidance aimed at speeding biosimilar time to market and lower costs, and more in the latest National Advocacy Update.

Advocacy Update